Opparounds

Efficacy and Tolerability of Seven Antipsychotic Drugs in Acutely Ill Patients With Schizophrenia: A Randomized, Multicenter, Assessor-Blinded Trial

Zhao G, Sun Y, Zhang Y, et al. · American Journal of Psychiatry · February 2026

The SINO trial randomized 3,067 acutely hospitalized patients with schizophrenia across 32 Chinese hospitals to six weeks of flexible-dose monotherapy with one of seven antipsychotics — olanzapine, risperidone, quetiapine, aripiprazole, ziprasidone, perphenazine, or haloperidol. Olanzapine and risperidone outperformed aripiprazole, quetiapine, and ziprasidone on symptom reduction, but not the two first-generation drugs; overall efficacy differences across all seven were modest.

Tolerability, by contrast, diverged sharply: olanzapine caused the most weight gain, aripiprazole the least sedation and lowest prolactin elevation, and haloperidol the most extrapyramidal symptoms.

Read the paper →  doi:10.1176/appi.ajp.20250111

Supervised Therapist and Supervisor Impact on Client Therapy Outcomes

Vogeler HA, Allphin K, Merrill BM, Fischer L · Psychotherapy Research · July 2026

Using hierarchical linear modeling across 4,691 clients, 146 supervised trainee-therapists, and 43 supervisors at a college counseling center, this study asked whether client outcomes (measured via the OQ-45.2) track more with the individual trainee or with which supervisor they were assigned. Trainee-therapist effects significantly predicted outcomes — a modest but real share of the variance — while direct supervisor effects on outcomes were not statistically significant.

Trainee experience level, and how it changed over the training year, was itself a significant predictor of outcome.

Read the paper →  doi:10.1080/10503307.2025.2548906

Buspirone Feels Safe Because Nobody Checks the CYP3A4 List

Buspirone rarely triggers interaction-checking reflexes — no black-box warnings, no routine levels, no QTc concern — which is exactly what makes a concomitant strong CYP3A4 inhibitor dangerous. Itraconazole raises buspirone's AUC by roughly 19-fold; other potent inhibitors (clarithromycin, ritonavir, nefazodone) produce comparable spikes.

At ordinary buspirone doses that magnitude of exposure produces genuine toxicity — dizziness, sedation, and hypotension that get mistaken for the anxiety itself. The labeled fix is not "monitor closely," it is a specific dose reduction to 2.5 mg once daily when buspirone must be combined with a strong CYP3A4 inhibitor, titrated back up only as the interacting drug is tapered off. The clinical trap is durational: a short azole antifungal course or a brief clarithromycin prescription is exactly the kind of "temporary, unrelated" medication nobody reconciles against a standing buspirone order — so the interaction shows up as a new complaint, not a flagged alert.

Follow the Affectively Dominant Theme, Not the Stated Topic

TFP's technique of tracking affect dominance rests on the observation that what a borderline- or narcissistic-organized patient talks about in a session and what is emotionally live in the room are frequently two different things. The stated topic — a work conflict, a scheduling complaint — can be affectively flat, while an interaction earlier in the same hour (being kept waiting, a comment about the therapist's vacation) carries the actual charge.

The technique is to scan for where affect is concentrated regardless of content, and address that first, even if it means setting aside the patient's chosen topic. This isn't disregarding the patient's agenda — it's recognizing that low-intensity material discussed at length is often defensive, while the affectively loaded moment, even if brief, is where the object relations dyad is actually being enacted.